GB0413726D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0413726D0
GB0413726D0 GBGB0413726.1A GB0413726A GB0413726D0 GB 0413726 D0 GB0413726 D0 GB 0413726D0 GB 0413726 A GB0413726 A GB 0413726A GB 0413726 D0 GB0413726 D0 GB 0413726D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0413726.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lauras AS
Original Assignee
Lauras AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lauras AS filed Critical Lauras AS
Priority to GBGB0413726.1A priority Critical patent/GB0413726D0/en
Publication of GB0413726D0 publication Critical patent/GB0413726D0/en
Priority to US11/629,908 priority patent/US8153609B2/en
Priority to AU2005254790A priority patent/AU2005254790B2/en
Priority to EP05755520.3A priority patent/EP1765844B1/en
Priority to DK05755520.3T priority patent/DK1765844T3/da
Priority to CA2568907A priority patent/CA2568907C/en
Priority to PCT/GB2005/002418 priority patent/WO2005123755A2/en
Priority to CNA2005800259528A priority patent/CN101001865A/zh
Priority to JP2007516050A priority patent/JP5044750B2/ja
Priority to ES05755520.3T priority patent/ES2496946T3/es
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/213—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids containing cyclic phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
GBGB0413726.1A 2004-06-18 2004-06-18 Compounds Ceased GB0413726D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB0413726.1A GB0413726D0 (en) 2004-06-18 2004-06-18 Compounds
ES05755520.3T ES2496946T3 (es) 2004-06-18 2005-06-20 Derivados de nucleótidos de purina
DK05755520.3T DK1765844T3 (da) 2004-06-18 2005-06-20 Purin-nukleotidderivater
AU2005254790A AU2005254790B2 (en) 2004-06-18 2005-06-20 Purine nucleotide derivatives
EP05755520.3A EP1765844B1 (en) 2004-06-18 2005-06-20 Purine nucleotide derivatives
US11/629,908 US8153609B2 (en) 2004-06-18 2005-06-20 Purine nucleotide derivatives
CA2568907A CA2568907C (en) 2004-06-18 2005-06-20 8-carbyl substituted cyclic adenosine-3',5'-monophosphorothiolate compounds as camp modulators
PCT/GB2005/002418 WO2005123755A2 (en) 2004-06-18 2005-06-20 Purine nucleotide derivatives
CNA2005800259528A CN101001865A (zh) 2004-06-18 2005-06-20 嘌呤核苷酸衍生物
JP2007516050A JP5044750B2 (ja) 2004-06-18 2005-06-20 プリンヌクレオチド誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0413726.1A GB0413726D0 (en) 2004-06-18 2004-06-18 Compounds

Publications (1)

Publication Number Publication Date
GB0413726D0 true GB0413726D0 (en) 2004-07-21

Family

ID=32750205

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0413726.1A Ceased GB0413726D0 (en) 2004-06-18 2004-06-18 Compounds

Country Status (10)

Country Link
US (1) US8153609B2 (enExample)
EP (1) EP1765844B1 (enExample)
JP (1) JP5044750B2 (enExample)
CN (1) CN101001865A (enExample)
AU (1) AU2005254790B2 (enExample)
CA (1) CA2568907C (enExample)
DK (1) DK1765844T3 (enExample)
ES (1) ES2496946T3 (enExample)
GB (1) GB0413726D0 (enExample)
WO (1) WO2005123755A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007006544A2 (en) * 2005-07-12 2007-01-18 Vrije Universiteit Brussel Cyclic adenosine monophosphate compounds for the treatment of immune-related disorders
GB0618235D0 (en) * 2006-09-15 2006-10-25 Lauras As Process
SI2448968T1 (sl) * 2009-06-29 2021-07-30 Bioarctic Ab Protitelesa, selektivna za protofibrile/oligomere na N-koncu skrajšanega amiloida-beta
WO2012040127A1 (en) 2010-09-22 2012-03-29 Alios Biopharma, Inc. Substituted nucleotide analogs
US8772474B2 (en) 2010-12-22 2014-07-08 Alios Biopharma, Inc. Cyclic nucleotide analogs
KR102072041B1 (ko) 2011-12-22 2020-01-31 앨리오스 바이오파마 인크. 치환된 뉴클레오사이드, 뉴클레오타이드 및 그의 유사체
EP2794630A4 (en) 2011-12-22 2015-04-01 Alios Biopharma Inc SUBSTITUTED PHOSPHORTHIOAT NUCLEOTIDE ANALOGUE
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
NZ631601A (en) 2012-03-21 2016-06-24 Alios Biopharma Inc Solid forms of a thiophosphoramidate nucleotide prodrug
NZ630805A (en) 2012-03-22 2016-01-29 Alios Biopharma Inc Pharmaceutical combinations comprising a thionucleotide analog
WO2022216577A1 (en) * 2021-04-09 2022-10-13 Merck Sharp & Dohme Llc Novel forms of cyclic dinucleotide compounds
US20240352056A1 (en) 2021-09-06 2024-10-24 Mireca Medicines Gmbh Improved methods for production of cyclic guanosine-monophosphate analogues

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968101A (en) 1974-12-20 1976-07-06 Icn Pharmaceuticals, Inc. 8-Substituted cyclic nucleotides by free radical alkylation and acylation
WO1989007108A1 (en) * 1988-02-01 1989-08-10 Bernd Jastorff Process for producing nucleoside-3',5'-cyclophosphates and nucleoside-3',5'-cyclothiophosphates
AU4226693A (en) 1992-05-01 1993-11-29 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Phosphorothioate derivatives of cyclic AMP analogues
US5625056A (en) 1992-05-26 1997-04-29 Biolog Life Science Institute Derivatives of cyclic guanosine-3',5'-monophosphorothioate
NO971997D0 (no) 1997-04-29 1997-04-29 Kjetil Tasken Bruk av immunmodulerende midler
AU2003242672B2 (en) * 2002-06-07 2009-12-17 Universitair Medisch Centrum Utrecht New compounds for modulating the activity of exhange proteins directly activated by camp (EPACS)

Also Published As

Publication number Publication date
EP1765844A2 (en) 2007-03-28
WO2005123755A3 (en) 2006-04-06
AU2005254790B2 (en) 2012-02-23
EP1765844B1 (en) 2014-07-30
AU2005254790A1 (en) 2005-12-29
CA2568907C (en) 2015-06-09
JP5044750B2 (ja) 2012-10-10
ES2496946T3 (es) 2014-09-22
CA2568907A1 (en) 2005-12-29
WO2005123755A2 (en) 2005-12-29
DK1765844T3 (da) 2014-09-01
US8153609B2 (en) 2012-04-10
US20080293665A1 (en) 2008-11-27
CN101001865A (zh) 2007-07-18
JP2008502673A (ja) 2008-01-31

Similar Documents

Publication Publication Date Title
GB0405933D0 (en) Compounds
GB0405937D0 (en) Compounds
IL178330A0 (en) Neurologically-active compounds
GB0405193D0 (en) Compounds
ZA200610701B (en) Compounds
GB0401269D0 (en) Compounds
GB0405272D0 (en) Compounds
GB0405101D0 (en) Compounds
GB0405267D0 (en) Compounds
GB0405280D0 (en) Compounds
GB0405893D0 (en) Compounds
GB0403593D0 (en) Compounds
GB0403595D0 (en) Compounds
GB0405936D0 (en) Compounds
GB0404104D0 (en) Compounds
GB0405899D0 (en) Compounds
GB0403990D0 (en) Compounds
ZA200609074B (en) Neurologically-active compounds
GB0400696D0 (en) Compounds
GB0404083D0 (en) Compounds
GB0403993D0 (en) Compounds
GB0423000D0 (en) Compounds
GB0405248D0 (en) Compounds
GB0401657D0 (en) Compounds
GB0400695D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)